2010年内脏利什曼病的治疗：来自印度比哈尔邦的指导意见。 - Suppr

Suppr

超能文献

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

作者信息

Murray Henry W

出版信息

Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92.

DOI:10.2217/fmb.10.92

PMID:20860475

Abstract

摘要

相似文献

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92.

Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.

Trop Med Int Health. 2009 Jan;14(1):88-92. doi: 10.1111/j.1365-3156.2008.02195.x. Epub 2008 Dec 11.

Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.

Trop Med Int Health. 2009 Aug;14(8):918-25. doi: 10.1111/j.1365-3156.2009.02306.x. Epub 2009 Jun 28.

Drug combinations for visceral leishmaniasis.

Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d.

Combination therapy for visceral leishmaniasis.

Lancet. 2011 Feb 5;377(9764):443-4. doi: 10.1016/S0140-6736(10)62237-4. Epub 2011 Jan 20.

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.

Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20.

Injectable paromomycin for Visceral leishmaniasis in India.

N Engl J Med. 2007 Jun 21;356(25):2571-81. doi: 10.1056/NEJMoa066536.

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.

PLoS Negl Trop Dis. 2010 Sep 7;4(9):e818. doi: 10.1371/journal.pntd.0000818.

Leishmaniasis: an update of current pharmacotherapy.

Expert Opin Pharmacother. 2013 Jan;14(1):53-63. doi: 10.1517/14656566.2013.755515. Epub 2012 Dec 21.

Breakthrough in the management of visceral leishmaniasis.

J Assoc Physicians India. 2003 Jul;51:649-51.

引用本文的文献

Untargeted Liquid Chromatography-High-Resolution Mass Spectrometry Metabolomic Investigation Reveals Altered Lipid Content in Lacking Lipid Droplet Protein Kinase.

Trop Med Infect Dis. 2024 Sep 10;9(9):208. doi: 10.3390/tropicalmed9090208.

Need for sustainable approaches in antileishmanial drug discovery.

Parasitol Res. 2019 Oct;118(10):2743-2752. doi: 10.1007/s00436-019-06443-2. Epub 2019 Aug 31.

Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.

Antimicrob Agents Chemother. 2015 Oct;59(10):6463-70. doi: 10.1128/AAC.05131-14. Epub 2015 Aug 3.

Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.

PLoS Negl Trop Dis. 2013 May 2;7(5):e2195. doi: 10.1371/journal.pntd.0002195. Print 2013.

Antileishmanial activity of diterpene acids in copaiba oil.

Mem Inst Oswaldo Cruz. 2013 Feb;108(1):59-64. doi: 10.1590/s0074-02762013000100010.

Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani.

Parasitol Res. 2013 Feb;112(2):825-8. doi: 10.1007/s00436-012-3212-3. Epub 2012 Dec 13.

Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol.

PLoS Negl Trop Dis. 2012;6(5):e1664. doi: 10.1371/journal.pntd.0001664. Epub 2012 May 29.

Integrated dataset of screening hits against multiple neglected disease pathogens.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1412. doi: 10.1371/journal.pntd.0001412. Epub 2011 Dec 20.

Leishmania antimony resistance: what we know what we can learn from the field.

Parasitol Res. 2011 Nov;109(5):1225-32. doi: 10.1007/s00436-011-2555-5. Epub 2011 Jul 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验